Dakota Wealth Management’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-30,665
Closed -$400K 755
2024
Q1
$400K Hold
30,665
0.01% 537
2023
Q4
$391K Hold
30,665
0.02% 460
2023
Q3
$402K Buy
30,665
+4
+0% +$73 0.02% 452
2023
Q2
$784K Buy
30,661
+7,161
+30% +$185K 0.04% 291
2023
Q1
$592K Buy
23,500
+3,500
+18% +$82.2K 0.04% 333
2022
Q4
$460K Sell
20,000
-15,500
-44% -$357K 0.03% 364
2022
Q3
$783K Sell
35,500
-50,074
-59% -$969K 0.06% 248
2022
Q2
$1.23M Hold
85,574
0.11% 168
2022
Q1
$1.62M Buy
+85,574
New +$1.66M 0.13% 165

Other funds holding TMCI

Dakota Wealth Management's TMCI Position: Q2 2024 in Review

Dakota Wealth Management sold out of Treace Medical Concepts (TMCI) in Q2 2024, closing a stake of 30,665 shares — an estimated $400K sold.

Dakota Wealth Management first reported a position in TMCI in Q1 2022 and held it in 9 quarters. The position peaked at $1.62M in Q1 2022. 127 funds tracked by Wall St. Rank hold TMCI as of Q2 2024.

  • Dakota Wealth Management reported no remaining Treace Medical Concepts position as of Q2 2024 after selling out during the quarter.
  • Dakota Wealth Management sold 30,665 Treace Medical Concepts shares in Q2 2024, an estimated $400K.
  • Dakota Wealth Management first reported a position in Treace Medical Concepts in Q1 2022 and held it in 9 quarters.
  • Dakota Wealth Management's Treace Medical Concepts position peaked at $1.62M in Q1 2022.
  • 127 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2024.

Based on Dakota Wealth Management's 13F filing for Q2 2024, filed 22 Jul 2024.